Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy — Clinical Trial Site

111 Registered trials

43 Currently recruiting

Organisation

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Location

Bydgoszcz, Poland

Identifier

ORG-100043365

Address

Ul. Kornela Ujejskiego 75, 85-168, Poland

Departments

"Szpital Biziela" Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
#2201: Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
#2316:Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej
#3201 - Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
#3201:Klinika Reumatologii i Ukladowych Chorb Tkanki Lacznej
#3506: Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
#40119:Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej
#419: Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej
161606: Klinika Hematologii
1801 : Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
3046: Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
3506: Klinika Reumatologii i Układowych Chorób Tkanki Łączne
40119: Klinika Reumatologii i Układowych Chorob Tkanki Lacznej
Cardiology
Clinic of Rheumatology and Systemic Diseases of Connective Tissue
Department of Hematology
Department of Otolaryngology and Laryngological Oncology
Department of Rheumatology and Connective Tissue Diseases
Gastroenterology
Haematology
Hematologia
Hematologii
Katedra Hematologii
Katedra Kardiologii i Farmakologii Klinicznej
Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
Klinika Alergologii, Immunologii Klinicznej i Chorób Wewnętrznyc
Klinika Alergologii, Immunologii Klinicznej i Chorob Wewnetrznych
Klinika Angiologii
Klinika Gastroenterologii
Klinika Hematologii
Klinika Kardiologi
Klinika Kardiologii
Klinika Kardiologii, Farmakologii Klinicznej i Chorób Wewnętrznych
Klinika Neurochirurgii i Neurologii, Centrum Interwencyjnego Leczenia Udarów Mózgu
Klinika Neurologii
Klinika Reumatolgii i Ukladowych Chorob Tkanki Łacznej
Klinika Reumatologii i
Klinika Reumatologii i Ukladowych Chorob Tkanki laczne
Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej
Klinika Reumatologii i Układowych Chorob Tkanki Lacznej
Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
Klinika Reumatologii i Układowych Chorób Tkanki Łącznej Chorób Tkanki Łącznej
N/A
NA
Neurology
Oddział noworodkowy
PL10004: Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej
reumathology
Rheumatology
Szpital Uniwersytecki Nr 2 im Biziela, Klinika Reumatologii i Układowych Chorób Tkanki Łącznej
Szpital Uniwersytecki Nr 2 w Bydgoszczy, Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej

Clinical trials at this site (111)

Search interface

A clinical study of tulisokibart in people with rheumatoid arthritis (MK-7240-014) Ended

2025-521745-25-00 Rheumatoid Arthritis 4 2025-11-06
Trial of Sibeprenlimab in the Treatment of Sjögren’s Disease Ended

2024-516295-14-00 Treatment of Sjögren’s disease 4 2025-09-17
A study of Navenibart in Participants with Hereditary Angioedema Ended

2025-521660-35-00 Hereditary Angioedema 5 2025-09-11
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended

2023-509239-19-00 Active Psoriatic Arthritis 5 2025-04-03
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active… Ended

2024-516213-20-00 Psoriatic arthritis 5 2025-03-25
A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab … Ended

2024-511933-36-00 Diffuse cutaneous systemic sclerosis (dcSSc) 4 2025-01-02
A research study to evaluate the efficacy and safety of cenerimod in subjects suffering from systemic lupus erythematosus Ended

2024-515871-37-00 Moderate to severe systemic lupus erythematosus 5 2024-10-24
A Study to Assess the Efficacy and Safety of Golcadomide and Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lympho… Ended

2024-511304-16-00 Newly Diagnosed Advanced Stage Follicular Lymphoma 4 2024-10-10
Clinical trial testing an investigational drug RVU120 for myelofibrosis (myeloproliferative neoplasm, MPN) Ended

2024-511688-27-00 Myelofibrosis 4 2024-09-19
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A Study to Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants with Previously Untreated High-… Ended

2023-510178-15-00 High-risk Large B-cell Lymphoma 5 2024-07-31
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome Ended

2023-503923-24-00 Sjögren’s Syndrome With Moderate-toSevere Symptom State 5 2024-07-22
Determine effectiveness of Anifrolumab In Systemic sclerosis Ended

2023-505976-31-00 Systemic Sclerosis (SSc) presenting with Limited or Dif 5 2023-11-24
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjögren’… Ended

2022-502966-26-01 Sjögren’s syndrome 5 2023-10-27
Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE Ended

2022-502105-15-00 Systemic lupus erythematosus 4 2023-10-20
A multicenter study of secukinumab, with a randomized double-blind, placebo-controlled withdrawal-retreatment period, to evaluate maintenanc… Ended

2023-509320-17-00 non-radiographic axial spondyloarthritis 6 2023-03-28
A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy Ended

2024-512785-33-00 Active Idiopathic Inflammatory Myopathy (IIM) 10 2023-03-01
Phase 3 study to evaluate two regimens of ianalumab on top of standardof- care therapy in patients with systemic lupus erythematosus (SIRIUS… Ended

2023-508498-97-00 Systemic Lupus Erythematosus 5 2023-02-03
Efficacy and Safety Study of Nipocalimab for Adults with Active Inflammatory Myopathies Ended

2023-505314-20-00 Active Idiopathic Inflammatory Myopathies (IIM) 4 2023-01-20
A Phase 3 study of Tafasitamab plus Lenalidomide in patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Ended

2023-505579-53-00 Diffuse large B-cell lymphoma (DLBCL) 5 2022-10-25
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients with Paroxysmal Nocturnal… Ended

2023-509657-31-00 Paroxysmal nocturnal haemoglobinuria (PNH) 5 2022-08-24
A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD) Ended

2023-505635-13-00 Systemic lupus erythematosus 5 2022-06-10